Imaging of the brain serotonin transporters (SERT) with 18F-labelled fluoromethyl-McN5652 and PET in humans
- PMID: 22349718
- DOI: 10.1007/s00259-012-2078-z
Imaging of the brain serotonin transporters (SERT) with 18F-labelled fluoromethyl-McN5652 and PET in humans
Abstract
Purpose: [(11)C]DASB is currently the most frequently used highly selective radiotracer for visualization and quantification of central SERT. Its use, however, is hampered by the short half-life of (11)C, the moderate cortical test-retest reliability, and the lack of quantifying endogenous serotonin. Labelling with (18)F allows in principle longer acquisition times for kinetic analysis in brain tissue and may provide higher sensitivity. The aim of our study was to firstly use the new highly SERT-selective (18)F-labelled fluoromethyl analogue of (+)-McN5652 ((+)-[(18)F]FMe-McN5652) in humans and to evaluate its potential for SERT quantification.
Methods: The PET data from five healthy volunteers (three men, two women, age 39 ± 10 years) coregistered with individual MRI scans were semiquantitatively assessed by volume-of-interest analysis using the software package PMOD. Rate constants and total distribution volumes (V (T)) were calculated using a two-tissue compartment model and arterial input function measurements were corrected for metabolite/plasma data. Standardized uptake region-to-cerebellum ratios as a measure of specific radiotracer accumulation were compared with those of a [(11)C]DASB PET dataset from 21 healthy subjects (10 men, 11 women, age 38 ± 8 years).
Results: The two-tissue compartment model provided adequate fits to the data. Estimates of total distribution volume (V (T)) demonstrated good identifiability based on the coefficients of variation (COV) for the volumes of interest in SERT-rich and cortical areas (COV V (T) <10%). Compared with [(11)C]DASB PET, there was a tendency to lower mean uptake values in (+)-[(18)F]FMe-McN5652 PET; however, the standard deviation was also somewhat lower. Altogether, cerebral (+)-[(18)F]FMe-McN5652 uptake corresponded well with the known SERT distribution in humans.
Conclusion: The results showed that (+)-[(18)F]FMe-McN5652 is also suitable for in vivo quantification of SERT with PET. Because of the long half-life of (18)F, the widespread use within a satellite concept seems feasible.
Similar articles
-
Autoradiographic imaging of the serotonin transporter in the brain of rats and pigs using S-([18F]fluoromethyl)-(+)-McN5652.Eur Neuropsychopharmacol. 2003 Oct;13(5):387-97. doi: 10.1016/s0924-977x(03)00039-7. Eur Neuropsychopharmacol. 2003. PMID: 12957338
-
In vivo measurement of the serotonin transporter with (S)-([18F]fluoromethyl)-(+)-McN5652.Neuropsychopharmacology. 2003 Nov;28(11):2010-9. doi: 10.1038/sj.npp.1300281. Neuropsychopharmacology. 2003. PMID: 12931143
-
S-[18F]fluoromethyl-(+)-McN5652, a PET tracer for the serotonin transporter: evaluation in rats.Synapse. 2003 Jan;47(1):45-53. doi: 10.1002/syn.10150. Synapse. 2003. PMID: 12422372
-
trans-(+)-1,2,3,5,6,10b-Hexahydro-6-(4-([11C]methylthio)-phenyl)pyrrolo-(2,1-a)-isoquinoline.2006 Mar 7 [updated 2006 Apr 12]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2006 Mar 7 [updated 2006 Apr 12]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641500 Free Books & Documents. Review.
-
2-((2-Amino-4-chloro-5-[18F]fluorophenyl)thio)-N,N-dimethylbenzenmethanamine.2006 Feb 13 [updated 2006 Feb 27]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2006 Feb 13 [updated 2006 Feb 27]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641424 Free Books & Documents. Review.
Cited by
-
Preliminary Results on the Long-Term Effects of Dextromethorphan on MDMA-Mediated Serotonergic Deficiency and Volumetric Changes in Primates Based on 4-[18F]-ADAM PET/MRI.Front Neurosci. 2022 May 19;16:837194. doi: 10.3389/fnins.2022.837194. eCollection 2022. Front Neurosci. 2022. PMID: 35692422 Free PMC article.
-
Central noradrenaline transporter availability in highly obese, non-depressed individuals.Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1056-1064. doi: 10.1007/s00259-016-3590-3. Epub 2017 Jan 9. Eur J Nucl Med Mol Imaging. 2017. PMID: 28066877 Free PMC article. Clinical Trial.
-
Ventral striatal dopamine transporter availability is associated with lower trait motor impulsivity in healthy adults.Transl Psychiatry. 2018 Dec 7;8(1):269. doi: 10.1038/s41398-018-0328-y. Transl Psychiatry. 2018. PMID: 30531858 Free PMC article.
-
Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging.Curr Med Chem. 2016;23(18):1818-69. doi: 10.2174/0929867323666160418114826. Curr Med Chem. 2016. PMID: 27087244 Free PMC article. Review.
-
Toxicity and radiation dosimetry studies of the serotonin transporter radioligand [(18) F]AFM in rats and monkeys.EJNMMI Res. 2014 Dec;4(1):71. doi: 10.1186/s13550-014-0071-1. Epub 2014 Dec 29. EJNMMI Res. 2014. PMID: 26116128 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources